Russell Investments Group
CMPX icon

Russell Investments Group’s Compass Therapeutics CMPX Stock Holding History

Russell Investments Group’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
50,505
+39,605
+363% +$117K ﹤0.01% 3418
2026
Q1 		$57.7K Sell
10,900
-658
-6% -$3.8K ﹤0.01% 3278
2025
Q4 		$62.1K Buy
11,558
+3,773
+48% +$17.4K ﹤0.01% 3217
2025
Q3 		$27.2K Buy
7,785
+7,592
+3,934% +$24K ﹤0.01% 3499
2025
Q2 		$502 Hold
193
– – ﹤0.01% 3744
2025
Q1 		$367 Hold
193
– – ﹤0.01% 3699
2024
Q4 		$280 Buy
+193
New +$321 ﹤0.01% 3645

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Russell Investments Group's CMPX Position: Q2 2026 in Review

Russell Investments Group increased its Compass Therapeutics (CMPX) stake by 363% in Q2 2026, buying an estimated $117K and bringing the position to 50,505 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #3418.

Russell Investments Group first reported a position in CMPX in Q4 2024 and has held it in 7 quarters since. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Russell Investments Group held 50,505 shares of Compass Therapeutics worth $111K as of Q2 2026.
  • Russell Investments Group bought 39,605 Compass Therapeutics shares in Q2 2026, an estimated $117K.
  • Compass Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3418 holding.
  • Russell Investments Group first reported a position in Compass Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.